Scandinavian ChemoTech provides update on pancreas patients in Ukraine – aims for multinational TSE-studies in cooperation with partners as the next step
In September 2022, two locally advanced pancreatic cancer patients received TSE treatment at Ulis Hospital in Ukraine by open surgery. The follow-up CT scan of the patients showed a 50% decrease in the tumour mass, without post-operative complications. Achieving a 50% reduction of the tumour in cases which are not fit for surgery, as with these two patients, with only a single application of TSE is highly unusual in pancreatic cancer care and needs to be researched more to further optimize the treatment. The options to be explored are multiple applications via minimally invasive routes (